YEVGENIYA MYKHAYLEVSKA: Open Payments
NPI 1548974066 · MARINA DEL REY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,560 in 118 payments from 15 companies in 2025. Trend: 2023 $1,339 · 2024 $4,139 · 2025 $3,560
Food & beverage: $3,560
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 45 | $1,000 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $605 |
| E.R. Squibb & Sons, L.L.C. | 13 | $337 |
| Alkermes, Inc. | 3 | $250 |
| Axsome Therapeutics, Inc. | 5 | $242 |
| ABBVIE INC. | 10 | $220 |
| Neurocrine BioSciences, Inc. | 4 | $194 |
| Collegium Pharmaceutical, Inc. | 4 | $146 |
| Luye Pharma (USA) Ltd. | 2 | $145 |
| Tris Pharma Inc | 5 | $144 |
Products named: AUSTEDO XR, CAPLYTA, COBENFY, UZEDY, Auvelity, VRAYLAR, INGREZZA, Jornay PM.
Industry payments across CA — which companies pay providers there.
